A validated and standardized pseudotyped microneutralization assay as a safe and powerful tool to measure LASSA virus neutralising antibodies for vaccine development and comparison
F1000Research · 2024
DOI: 10.12688/f1000research.149578.2 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift F1000Research, 2024. Verfasst von Roberta Antonelli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Vismederi, Siena, Italy, 53100, Italy. Hauptthemen laut MEDLINE: Lassa virus, Antibodies, Neutralizing, Neutralization Tests, Antibodies, Viral. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: not applicable.
Abstract (Originalsprache)
Background
Over the past few decades, World Health Organization (WHO) has made massive efforts to promote the development of a vaccine against Lassa virus (LASV), one of the top ten priority pathogens for research and development under the WHO R&D Blueprint for Emerging Infections. To date, several vaccines are at different stages of development. In this scenario, a validated and standardised assay to measure LASV neutralising antibodies is urgently needed for vaccine development and comparison.
Methods
The neutralisation assay remains the gold standard for determining antibody efficacy. Here we have proposed a safe and validated pseudotyped neutralisation assay for LASV, taking advantage of the development of the first WHO International Standard and Reference Panel for Anti-Lassa Fever (NIBSC code 21/332). Results and Conclusions The proposed results demonstrate that the pseudotyped luciferase neutralisation assay is a specific serological test for the measurement of LASV neutralising antibodies without cross-reacting with standard sera specific for heterologous viral infections. In addition, the assay is accurate, precise, and linear according to criteria and statistical analyses defined and accepted by international guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vismederi, Siena, Italy, 53100, Italy.
- Life-Science, University of Siena, Siena, Italy.
- Viral Pseudotype Unit, Medway School of Pharmacy,, University of Kent and Greenwich at Medway, Chatham, Kent, UK.
- Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
ORCID-Profile: Roberta Antonelli, Vittoria Forconi
Förderung
- not applicable
Zitieren
APA
Antonelli, R., Forconi, V., Molesti, E., Semplici, C., Piu, P., Altamura, M., Dapporto, F., Temperton, N., Montomoli, E., & Manenti, A. (2024). A validated and standardized pseudotyped microneutralization assay as a safe and powerful tool to measure LASSA virus neutralising antibodies for vaccine development and comparison. F1000Research. https://doi.org/10.12688/f1000research.149578.2
Vancouver
Antonelli R, Forconi V, Molesti E, Semplici C, Piu P, Altamura M, et al. A validated and standardized pseudotyped microneutralization assay as a safe and powerful tool to measure LASSA virus neutralising antibodies for vaccine development and comparison. F1000Research. 2024. doi:10.12688/f1000research.149578.2
BibTeX
@article{Antonelli2024,
author = {Antonelli, Roberta and Forconi, Vittoria and Molesti, Eleonora and Semplici, Claudia and Piu, Pietro and Altamura, Maria and Dapporto, Francesca and Temperton, Nigel and Montomoli, Emanuele and Manenti, Alessandro},
title = {A validated and standardized pseudotyped microneutralization assay as a safe and powerful tool to measure LASSA virus neutralising antibodies for vaccine development and comparison},
journal = {F1000Research},
year = {2024},
doi = {10.12688/f1000research.149578.2}
}
EUVIMED